Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Co-Principal Investigator
Dose reduction of edoxaban preserves efficacy and safety for the treatment of venous thromboembolism. An analysis of the randomised, double-blind HOKUSAI VTE trial.
Product Packaging
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.
Principal Investigator
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Principal Investigator
Overview
researcher role of
Mannel, Robert
contributes to
Stephenson Cancer Center - Cancer Center Support Grant